CURRICULUM VITAE. Environment, Occupational Health and Safety)

Size: px
Start display at page:

Download "CURRICULUM VITAE. Environment, Occupational Health and Safety)"

Transcription

1 CURRICULUM VITAE PERSONAL INFORMATION Name DIMITRIU LAVINIA CRISTINA Nationality Romanian Date of birth 13 August 1957 Sex Employer / Field of activity WORK EXPERIENCE female Antibiotice Quality Unit 25 September 2007 to date Quality Director in the quality management system according to GMP requirements, Management Representative on the Integrated Management System (Quality, Environment, Occupational Health and Safety) and qualified person in manufacture/import of pharmaceutical products for human use. Planning, organizing and coordinating the Quality Department to ensure compliance with regulatory requirements for the manufacture of pharmaceutical products and active substances Organizing and coordinating the establishment, implementation, maintenance and development of requirements for the integrated management system (quality, environment, occupational health and safety) Assessing and enforcing compliance with GMP requirements in the planning and realization of investments Performing the incumbent as a Qualified person Manufacture of basic pharmaceutical products 23 September 2005 to date Quality Director in the quality management system according to GMP requirements, Management Representative on the Integrated Management System (Quality, Environment, Occupational Health and Safety) Planning, organizing and coordinating the Quality Department to ensure compliance with regulatory requirements for the manufacture of pharmaceutical products and active substances Guaranteeing that each batch of finished product released on the market was produced and tested/controlled in accordance with the GMP requirements, national applicable regulations and the MA. Manufacture of medicines and pharmaceutical products January 2003 to date Quality Director ( Quality Assurance and Quality Control) Planning, organizing and coordinating the Quality Department activity to ensure compliance with regulatory requirements for the manufacture of pharmaceutical products and active substances Guaranteeing that each batch of finished product released on the market was produced and tested /controlled in accordance with the GMP requirements, national applicable regulations. Manufacture of medicines and pharmaceutical products 1

2 August 2000 January 2003 Quality (Laboratory of physico-chemical and microbiological analyses) Quality Control Manager Manages and organizes laboratory work of physico - chemical and microbiological analyses Manufacture of medicines and pharmaceutical products August 1990 August Production Manager, Parenteral Products Plant Planning, organizing and coordinating the activity within the Plant in view of achieving the production program at the quantity and a quality level set Achieving the production program, compliance with quality parameters stipulated in the specifications, contractual norms or arrangements, delivery terms stipulated in the contracts, both for the domestic market and for export Applying the most efficient methods for organizing, programming and monitoring production Improving the production flows and the work process Applying the research results in production and solving the productionrelated problems Manufacture of medicines and pharmaceutical products Foreman - Lysine Manufacture Coordination of the technological process development in the media preparation, biosynthesis and atomization installations, in shifts Manufacture of medicines and pharmaceutical products Technologist at the Design Center Făgăraş Chemical Factory Manufacture of polycondensation resins phenol - formaldehyde Head of the Quality Control Lab Făgăraş Chemical factory Manufacture of polycondensation resins phenol - formaldehyde Education and formation GMP September 2010 Certificate for continuous training 2

3 1. Training GMP for quality assurance and control, modules 1-8: Media fils ICH and FDA regulations on aseptic filling Recommendations for the validation of aseptic processes Media fill used for validation Media fill for routine use Training and qualification of staff Requirements for documentation 2. Monitoring environmental conditions Environmental considerations: standards, qualification and monitoring clean rooms Monitoring of airborne microbial load and non-viable particles Monitoring non-viable particles Microbial monitoring Monitoring interventions 3. Risk management system Risk management with an impact on quality (MRC) with respect to aseptic processes and finished products such as tablets, capsules, ointments and suppositories, active substances obtained by biosynthesis. MRC process Evaluation of risk, control, communication and revision Risk evaluation tools Risk analysis in 3-D, FMEA, HACCP, FTA The implications of risk analysis/evaluation on processing Implications of risk determination on the validation 4. Investigation of the primary cause for CAPA Cause-effect investigations CAPA process development Problems related to the human factor and CAPA training CAPA: Too much or not enough? Review 483 and CAPA quotes Using a closed system as the center of activity for quality management 5. Residual solvent testing Classification of solvents by risk analysis/assessment The interaction between laboratory and API manufacturer Selecting methodologies i. Screening methodologies ii. Method validation iii. Routine testing vs. qualification testing Chromatography Challenges from the past Case studies 6. Theory and Practice of Near IR (near-infrared) in the pharmaceutical industry What is the use of NIR? History and basic theory Applications in the Pharmaceutical Industry The price / benefit ratio in production and productivity The development of quantitative predictive models Using the portable NIR analyzers 3

4 7. Developing the HPLC method and validation procedures - Efficiency of the HPLC method development process i. critical components for the HPLC method ii. % time spent with various stages of development l iii. The elaboration of the method development experiment - Deadline for method development - Defining method objectives - Understanding the chemical aspects - Conditions of the initial method - Preparation of samples - Standardization - Optimizing method - Method validation 8. Pharmaceutical impurities - ICH requirements for the control of impurities in pharmaceutical products - Impurities associated with the API (active pharmaceutical ingredient) - Organic impurities - Inorganic impurities - Residues of solvents - Impurities concerning /concerned with formulation - Impurities during formulation - The formation of impurities during the "ageing" - Critical factors affecting the bulk product quality - Appropriate packaging - Use of the method of production based on the stability studies - Measures adopted by the Pharmacopoeia Novatek International September May June 2006 Conference Strategies for Compliant Pharma Sourcing EFCG (European Fine Chemicals Group) in Lisbon, Portugal Certificate attesting the capacity of qualified person in the manufacture/ import of medicinal products for human use Qualified person in the manufacture/ import of medicinal products for human use Ministry of Public Health, National Agency for Medicines, Bucharest Certificate for continuous training US-FDA Drug Submission Procedures Pharmaceutical Training International Millipore Biopharmaceutical Seminar Millipore, Bucharest, Romania 4

5 25 October 2005 Certificate for continuous training Millipore Steriltest School Course Millipore, Bucharest, Romania September 2005 Certificate for continuous training Aseptic Processing and Sterile Processes Institute of Validation Technology (SUA), with the participation of trainers from FDA Dublin January 2005 FDA s New Quality Systems and Risk Approach Heidelberg University, Germany 13 Decembrer 2004 Veterinary Generics in the E.U Management Forum, Lonon, UK November 2004 Certificate of continuous training CTD, CEP and DMF Quality of Drug Substance, European Compliance Academy, Barcelona, Spain September 2004 Certificate of continuous training Computer System & Software Validation Institute of Validation Technology (US), with the participation of trainers from FDA Dublin May 2004 Process Analytical Technologies EDQM, Cannes, France 14 October 2003 October Pharma Fest Symposium 5

6 TEKNOLEB, Bucharest 06 October 2003 Seminar: Le marche du flaconnage verre pharmaceutique et cosmetique Saint-Gobain Desjonqueres, Bucharest September 2003 Certificate of continuous training July 2003 Cleaning Validation of Critical Cleaning Processes Institute of Validation Technology (US) Dublin, Ireland Certificate of continuous training Pan European Regulatory Forum on Pharmaceuticals (PERF III) EMEA, Ljubliana, Slovenia 02 June 2003 Diploma of attendance Seminar New Analytical Methods for Pesticide Residues in Foods and Agricultural Products Agilrom Scientific, Buharest, Romania November 2002 Certificate of continuous training European Aseptic Conference European Compliance Academy, Barcelona, Spania Certificate of continuous training, ISO Course on Occupational health and Safety M.M.S.S.F Labor inspection 30 March 2006 Certificate no Environmental Management 31 March 02 aprilie 2006 Certificate no. A 256 Quasaro, lecturer eng. Tatiana Samoilă (Auditor of AFAQ-ASCERT International no. A00558, Head Auditor RENA no. A0107) Internal auditors for the Environmental Management System 6

7 03 April 2006 Certificate no April 2006 Certificate no. A November 2005 Certificate 06/0644 Quasaro, lecturer eng. Tatiana Samoilă (Auditor of AFAQ-ASCERT International no. A00558, Head Auditor RENA no. A0107) Management System for Occupational Health and Safety OHSAS Quasaro, lecturer eng. Tatiana Samoilă (Auditor of AFAQ-ASCERT International no. A00558, Head Auditor RENA no. A0107) Auditors for the Management System for Occupational Health and Safety Quasaro, lecturer eng. Tatiana Samoilă (Auditor of AFAQ-ASCERT International no. A00558, Head Auditor RENA no. A0107)) LRQA course for Auditor/ chief auditor for series ISO 9000:2000 International Register of Certificated Auditors IRCA 29 august 01 September 2005 certificate TRI-AK/05/16581 Specialist in Quality management TUV Rheinland InterCert Budapest Summer School a+, Edition III, module I Creativity, innovation and improvement, Lecturers from Alexandru Ioan Cuza University, Faculty of Economics and Business Administration Qualification / Diploma obtained Summer School a+, Edition II, module I Creativity and innovation, module III Labour legislation, modulul VI Methods of statistical analysis in quality assurance and quality control Lecturers from Alexandru Ioan Cuza University, Faculty of Economics and Business Administration

8 Summer school a+, Edition I, Management and development in the turbulence era Lecturers from Alexandru Ioan Cuza University, Faculty of Economics and Business Administration 2007 to date Doctoral School The faculty of Medicine and Pharmacy, Iasi Postgraduate studies MA in Pharmaceutical Management and Marketing The Faculty of Medicine and Pharmacy Iasi 10 March July 2005 Certificate of English upper intermediate English language course EuroEd foundation 19 October February 2005 The certificate of English language intermediate English language course EuroEd foundation 18 June 2004 National Symposium Quality is everybody s problem Quality - Management European Integration, Bucharest April 2003 Workshop on Designation and notification of regulatory bodies in the EU in the field covered by New Approach directives; Designation and notification of regulatory bodies in Romania in the field covered by Law no. 608/2001. RENAR Bucharest Postgraduate course on Organizational culture Alexandru Ioan Cuza University Iaşi 8

9 November 2000 Diploma of attendance National Symposium: Quality is everybody s problem RENA Bucharest Graduate School of management, stage I Gh. Asachi Technical University Iaşi December 1992 HR Management course Department of Education and Training within the Board of Commerce and Industry 23 November 12 December 1992 Training for using microcomputers Computer Training Center 15 April 19 April 1992 Personnel Management Course 11 March 22 March 1991 Department of Management and Training for the Domestic and Foreign Market, Antibiotice SA Industrial Management and Marketing Department of Management and Training for the Domestic and Foreign Market, Antibiotice SA Graduation Diploma Postgraduate specialization in Biotechnology Alexandru Ioan Cuza University Iaşi Graduation diploma The Faculty of Chemical Technology Gheorghe Asachi Polytechnic Institute, Iaşi 9

10 Personal skills and competences Perseverance Mother tongue Romanian Foreign languages Self-evaluation e Understanding Speaking Writing Europeann level (*) Listening Reading skills Conversation Oral production English French B2 C1 Independent Expert B2 Independent C1 Expert B2 B2 Independent Independent (*) Common European Framework of Reference for Languages B2 B2 Independent Independent writing C1 Expert C1 Expert Social skills and competences Organizational skills and competences Technical skills and competences Technical skills and competences Artistic skills and abilities Other skills and abilities Driver s license Additional information Interpersonal communication skills, efficiency, dynamism, team spirit, reliability, resistance to stress Coordination skills, planning and organization, ability to identify and solve problems, reviewing skills, leadership skills, decision making skills, strategic thinking Management skills, ability to evaluate and make decisions, ability to synthesize Microsoft Office: Word, Excel, Power Point B category Available upon request 10

Pharmaceutical Manufacturing and Engineering Catalog Excerpt

Pharmaceutical Manufacturing and Engineering Catalog Excerpt Pharmaceutical Manufacturing and Engineering Catalog Excerpt PME 530 Introduction to Pharmaceutical Manufacturing Pharmaceutical manufacturing is vital to the success of the technical operations of a pharmaceutical

More information

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team Claus Mortensen, Medicines Inspector Danish Medicines Agency Member of the EMEA PAT team EMEA progress and status what is needed to document scientific understanding in a PAT application EMEA PAT team

More information

ICH Q8, 9 & 10 and the Impact on the QP

ICH Q8, 9 & 10 and the Impact on the QP 1 ICH Q8, 9 & 10 and the Impact on the QP Peter H. Gough David Begg Associates phg@david-begg-associates.com 2 A New Approach to Regulation Approach to the regulation of pharmaceuticals is undergoing a

More information

Leader in Pharmaceutical Films

Leader in Pharmaceutical Films TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation

More information

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective 1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation

More information

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE 1992-2012: 20 YEARS OF EXPERIENCE 22-23 March 2012 EDQM, Strasbourg, France ABSTRACTS PLENARY SESSION, 22 March 2012 ABSTRACT 1.3 The Evolution

More information

Global GMP Harmonisation A Japanese Perspective

Global GMP Harmonisation A Japanese Perspective Global GMP Harmonisation A Japanese Perspective Yukio Hiyama, Ph.D. Chief, Third Section, Division of Drugs, National Institute of Health Sciences, The Ministry of Health Labour and Welfare, JAPAN ISPE

More information

peace of mind For from development to commercial supply

peace of mind For from development to commercial supply For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number

More information

Q8 and Q8 annex An industry Perspective

Q8 and Q8 annex An industry Perspective Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing December 2008 Q8 and Q8 annex An industry Perspective Brian Withers, Abbott Laboratories, United Kingdom I attend this conference

More information

PDA 71 Years of Connecting People, Science and Regulation

PDA 71 Years of Connecting People, Science and Regulation PDA 71 Years of Connecting People, Science and Regulation 1 I m happy to be here. Bom Dia. Estou feliz por estar aqui. Richard M. Johnson PDA President & CEO since 2009 38 years experience in US and International

More information

Importance of ICH Guidance in Fulfilling Process Validation Requirements

Importance of ICH Guidance in Fulfilling Process Validation Requirements Importance of ICH Guidance in Fulfilling Process Validation Requirements Presented by: Gamal Amer All rights reserved. Do not copy without permission. Principal 1 Premier Compliance Services, Inc. Process

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org

More information

Óbuda University Donát Bánki Faculty of Mechanical and Safety Engineering. TRAINING PROGRAM Mechatronic Engineering MSc. Budapest, 01 September 2017.

Óbuda University Donát Bánki Faculty of Mechanical and Safety Engineering. TRAINING PROGRAM Mechatronic Engineering MSc. Budapest, 01 September 2017. Óbuda University Donát Bánki Faculty of Mechanical and Safety Engineering TRAINING PROGRAM Mechatronic Engineering MSc Budapest, 01 September 2017. MECHATRONIC ENGINEERING DEGREE PROGRAM CURRICULUM 1.

More information

Curriculum Vitae. Personal information. Work experience. First name(s) / Surname(s) Eugen Cătălin PLATON

Curriculum Vitae. Personal information. Work experience. First name(s) / Surname(s) Eugen Cătălin PLATON Curriculum Vitae Personal information First name(s) / Surname(s) Eugen Cătălin PLATON Address(es) 17, Hlincea Street, bl. 1050, section B, 3 rd floor, apt. 10, 700715, Iasi, Romania Telephone(s) 0040 743

More information

Turning knowledge into success. SCHOTT FIOLAX Academy

Turning knowledge into success. SCHOTT FIOLAX Academy Turning knowledge into success. SCHOTT FIOLAX Academy 2 SCHOTT is an international technology group with 130 years of experience in the areas of specialty glasses and materials and advanced technologies.

More information

Training Prospectus Public Course Dates

Training Prospectus Public Course Dates Training Prospectus 2018 Public Course Dates Assuring Compliance in Life Science Operating extensively within the global pharmaceutical, biotech, medical device and related healthcare industries, the Honeyman

More information

Section heading. Strapline sub-heading

Section heading. Strapline sub-heading Section heading Strapline sub-heading Smart every time NextPharma stands out as your pharmaceutical development and manufacturing partner with fast, flexible and tailored solutions for markets worldwide

More information

Quality Risk Management

Quality Risk Management Quality Risk Management Iron Chef Edition Keith D. Gibbs kage and sui generis Ninja Project Management My story shapes my perspective Bachelor of Science work in Earth Science with focus on Hydrogeology.

More information

TERMS OF REFERENCE FOR CONSULTANTS

TERMS OF REFERENCE FOR CONSULTANTS Strengthening Systems for Promoting Science, Technology, and Innovation (KSTA MON 51123) TERMS OF REFERENCE FOR CONSULTANTS 1. The Asian Development Bank (ADB) will engage 77 person-months of consulting

More information

Claudio Pincus, President, The Quantic Group R. Owen Richards, President, Quantic Regulatory Services Daniel Pincus, Consultant, The Quantic Group

Claudio Pincus, President, The Quantic Group R. Owen Richards, President, Quantic Regulatory Services Daniel Pincus, Consultant, The Quantic Group FDA Compliance and Regulatory Symposium Understanding the FDA s Latest cgmp Guidances: Opportunities and Pitfalls Claudio Pincus, President, The Group R. Owen Richards, President, Regulatory Services Daniel

More information

Value Paper. Are you PAT and QbD Ready? Get up to speed

Value Paper. Are you PAT and QbD Ready? Get up to speed Value Paper Are you PAT and QbD Ready? Get up to speed PAT and Quality-by-Design As PAT and Quality -by-design (QbD) become an integral part of the regulatory framework, automation group ABB argues more

More information

ASEPTIC PROCESSING, TODAY AND FUTURE

ASEPTIC PROCESSING, TODAY AND FUTURE ASEPTIC PROCESSING, TODAY AND FUTURE Dublin, Ireland, 4 October 2018 Marco Delgado Rueda ALL RIGHTS RESERVED 2018 PAREXEL INTERNATIONAL CORP. AGENDA Today s Reality and Needs Issues and Probable Causes

More information

Quality Regulation under Revised Pharmaceutical Affair Law

Quality Regulation under Revised Pharmaceutical Affair Law Quality Regulation under Revised Pharmaceutical Affair Law Yukio Hiyama, Ph.D. Division of Drugs, National Institute of Health Sciences, the Ministry of Health, Labour and Welfare, Japan E mail hiyama@nihs.go.jp

More information

Kyiv National University of Trade and Economics Faculty of Trade and Marketing INFORMATION PACKAGE

Kyiv National University of Trade and Economics Faculty of Trade and Marketing INFORMATION PACKAGE Kyiv National University of Trade and Economics Faculty of Trade and Marketing INFORMATION PACKAGE European Credit Transfer and Accumulation System (ECTS) Field of knowledge Specialty Specialization Education

More information

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC

More information

Strategic Management of Innovative Development of the Russian Pharmaceutical Complex

Strategic Management of Innovative Development of the Russian Pharmaceutical Complex MPRA Munich Personal RePEc Archive Strategic Management of Innovative Development of the Russian Pharmaceutical Complex Natalia Klunko 2013 Online at https://mpra.ub.uni-muenchen.de/54381/ MPRA Paper No.

More information

PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS)

PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS) PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS) The Post-Graduates will acquire adequate scientific information regarding basic principles of Pharmaceutics including Cosmetology, Specialized drug

More information

2008 Course Programs Schedule

2008 Course Programs Schedule 2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)

More information

Technology Transfer as the Process of Pharmaceutical Quality System: Modelling Technology Transfer as a Process Strategy

Technology Transfer as the Process of Pharmaceutical Quality System: Modelling Technology Transfer as a Process Strategy Journal of Pharmacy and Pharmacology 5 (2017) 299-313 doi: 10.17265/2328-2150/2017.06.002 D DAVID PUBLISHING Technology Transfer as the Process of Pharmaceutical Quality System: Modelling Technology Transfer

More information

MA/INS/GMP/735037/2014 Annex 1 of the GMP Guidelines on Good Manufacturing Practice - Manufacture of Sterile Medicinal Products

MA/INS/GMP/735037/2014 Annex 1 of the GMP Guidelines on Good Manufacturing Practice - Manufacture of Sterile Medicinal Products 31 March, 2015 European Medicines Agency GMP/GDP Inspectors Working Group (GMP/GDP IWG) 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Subject: MA/INS/GMP/735037/2014 Annex 1 of the GMP

More information

Training Prospectus Public Course Dates

Training Prospectus Public Course Dates Training Prospectus 2019 Public Course Dates Honeyman Group Assuring Compliance in Life Science Operating extensively within the global pharmaceutical, biotech, medical device and related healthcare industries,

More information

the SPD company Dr Clive Simon, Principal, The SPD Company.

the SPD company Dr Clive Simon, Principal, The SPD Company. the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated

More information

Manufacture of medicinal products in Italy: challenges for the Italian Medicines Agency

Manufacture of medicinal products in Italy: challenges for the Italian Medicines Agency Manufacture of medicinal products in Italy: challenges for the Italian Medicines Agency Isabella Marta Coordinator Inspections and Certification Dept. Head Manufacturing Authorization Office Italian Medicines

More information

JUST SCRATCHING THE SERVICE

JUST SCRATCHING THE SERVICE CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5

More information

The International Pharmacopoeia Overview

The International Pharmacopoeia Overview The International Pharmacopoeia Overview Prepared by Caroline Mendy Technical Officer - Quality Assurance and Safety: Medicines The International Pharmacopoeia P Content & Scope WHO Expert Committee on

More information

Advisory Board. Advisory Board. Advisory Board (1) GMP Manual (Up05) Maas & Peither AG GMP Publishing

Advisory Board. Advisory Board. Advisory Board (1) GMP Manual (Up05) Maas & Peither AG GMP Publishing (1) Virginia G. Beakes-Read Genentech, USA Ginny works for Genentech, Inc., as the Director, Regulatory Policy Liaison, for the Strategic Operations Office in Washington, D.C. She works on a variety of

More information

PUBLIC TRAINING PROGRAM July - December 2018 VENUE: Petaling Jaya, Shah Alam, Kuala Lumpur, Penang, Johore, Kuching.

PUBLIC TRAINING PROGRAM July - December 2018 VENUE: Petaling Jaya, Shah Alam, Kuala Lumpur, Penang, Johore, Kuching. FOUR TRAINING PROVIDER ISO 9001 Quality Management System. Understanding & Implementing ISO 9001:2015. (CIDB-CCD)(SBL-Khas) 2 16-17 19-20 13-14 Effective Control of Project Documentation. NEW (CIDB-CCD)

More information

VENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA

VENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA WORLD COMPLIANCE SEMINARS SPEAKER:- BRIAN G. NADEL President of Brian G. Nadel, GMP Consulting, LLC. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry - 2017

More information

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D. Senior Scientist (for Quality) Pharmaceuticals and Medical Devices Agency (PMDA) MFDS Nov 11, 2016 1 Agenda Introduction of PMDA ICH Q12 QbD assessment

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring PDA Europe Training Course The Parenteral Drug Association presents: Mastering Environmental Monitoring 4-5 September 2018 Wattwil Switzerland Training & Education Program europe.pda.org PDA Education

More information

Implementing Quality Systems

Implementing Quality Systems Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving

More information

Pharmaceutical Process Development

Pharmaceutical Process Development Announcing the following Seminar to be conducted by IVEPE-SEV Pharmaceutical Process Development Factors in Scale-Up, Process Validation and Regulatory Considerations Course Topics Include: Solid Dosage

More information

APIs global business developments

APIs global business developments APIs global business developments Dr Gian Mario Baccalini EFCG Board Member, Chairman of EFCG Pharma Business Committee President & CEO, Euticals S.p.A., Italy EFCG Press Conference, 13th October 2015,

More information

HUMAN RESOURCE DEVELOPMENT STRATEGY NATIONAL NUCLEAR ENERGY AGENCY INDONESIA For FNCA Human Resource Development 2003 Guritno Lokollo

HUMAN RESOURCE DEVELOPMENT STRATEGY NATIONAL NUCLEAR ENERGY AGENCY INDONESIA For FNCA Human Resource Development 2003 Guritno Lokollo HUMAN RESOURCE DEVELOPMENT STRATEGY NATIONAL NUCLEAR ENERGY AGENCY INDONESIA For FNCA Human Resource Development 2003 Guritno Lokollo TRAINING TECHNOLOGY DEVELOPMENT Manpower development is one of the

More information

What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012

What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012 What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012 What We Heard Report: The Case for Change 1 Report of What We Heard: The Case for Change Consultation

More information

KEY HIGHLIGHTS WORKSHOP 2019

KEY HIGHLIGHTS WORKSHOP 2019 KEY HIGHLIGHTS aenvironmental Monitoring afacility Design apractical Case Studies avisual Inspection aclean Room Behaviours aprocess Simulations arecent 483s, warning Letters and EU Observations WORKSHOP

More information

TABLE OF CONTENTS DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) EXECUTIVE SUMMARY JUNE 2016 THE FINAL PHASE EXECUTIVE SUMMARY 2

TABLE OF CONTENTS DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) EXECUTIVE SUMMARY JUNE 2016 THE FINAL PHASE EXECUTIVE SUMMARY 2 DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) EXECUTIVE SUMMARY THE FINAL PHASE TABLE OF CONTENTS EXECUTIVE SUMMARY 2 COMMERCIALIZATION 3 4 REGULATORY 5 6 TECHNICAL 7 8 For more information,

More information

Science and mathematics

Science and mathematics Accreditation of HE Programmes (AHEP): Collated learning outcomes for six areas of learning Programmes accredited for IEng Engineering is underpinned by science and mathematics, and other associated disciplines,

More information

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson EU GMP Evolution or Revolution Scope and drivers for EU GMP changes August 2015 Gordon Farquharson EU & PIC/S Harmonisation at IWG level now Slide 2 PharmOut 2015 EU & PIC/S Harmonisation (1) What does

More information

Global Regulatory Update FDA, USP, EP and ICH Standards for Test Method Validation. Jane Weitzel

Global Regulatory Update FDA, USP, EP and ICH Standards for Test Method Validation. Jane Weitzel Global Regulatory Update FDA, USP, EP and ICH Standards for Test Method Validation Jane Weitzel mljweitzel@msn.com Jane Weitzel Biosketch Jane Weitzel has been working in analytical chemistry for over

More information

Challenges of Implementation of ICH Q 8

Challenges of Implementation of ICH Q 8 Challenges of Implementation of ICH Q 8 A Regulatory Perspective Dr. Susanne Keitel BioKorea, Seoul, September 2007 Overview of the Presentation ICH Q 8: Background; EU Experience Design Space Associated

More information

Environmental Protection Agency

Environmental Protection Agency Good Laboratory Management: Means compliance with the correct regulations for each individual study.. Environmental Protection Agency Established 1970 To enforce environmental protection standards Clean

More information

Dear all, Enjoy our Newsletter, CITIES Communication Team. Cofinanced by the European Regional Development Fund

Dear all, Enjoy our Newsletter, CITIES Communication Team. Cofinanced by the European Regional Development Fund Dear all, Welcome to our new Newsletter where you will find information, activities and everything you need to know about our project, CITIES - Creative Industries in Traditional Intercultural Spaces.

More information

The 13 th International Conference on Quality and Dependability - CCF an Outstanding Event in the Field

The 13 th International Conference on Quality and Dependability - CCF an Outstanding Event in the Field The 13 th International Conference on Quality and Dependability - CCF 2012 - an Outstanding Event in the Field The primary objective of the 13th International Conference on Quality and Dependability CCF

More information

CLICK TO ADD TITLE [SPEAKERS NAMES]

CLICK TO ADD TITLE [SPEAKERS NAMES] CLICK TO ADD TITLE [SPEAKERS NAMES] [DATE] Thanks to our generous sponsors 10th Global Health Supply Chain Summit, Accra (Ghana); Nov 15-17, 2017 Pharmaceutical Manufacturing in Ghana Challenges and Potential

More information

International Journal of Pharma and Bio Sciences PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY ABSTRACT

International Journal of Pharma and Bio Sciences PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY ABSTRACT Research Article Analytical Chemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY SARAVANA KUMAR.V

More information

API hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.

API hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy. API hapis High Potency Active Pharmaceutical Ingredients High Potency Active Pharmaceutical Ingredients Innovation made. Easy. 2 High Potency Active Pharmaceutical Ingredients High potency APIs are our

More information

Mastering Environmental Monitoring

Mastering Environmental Monitoring pda.org/eu/em2019 2019 PDA EUROPE TRAINING Mastering Environmental Monitoring 15-16 OCTOBER 2019 WATTWIL, SWITZERLAND CONNECTING PEOPLE SCIENCE AND REGULATION Training & Education Program europe.pda.org

More information

Future of Pharmaceutical Quality and the Path to Get There

Future of Pharmaceutical Quality and the Path to Get There Future of Pharmaceutical Quality and the Path to Get There Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research INTERPHEX 2018, April 18, 2018,

More information

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association

More information

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003 Progress in FDA s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003 Impetus for Initiative: Modernization and continuous improvement in pharmaceutical manufacturing sector slow compared

More information

Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences

Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Introduction to STP (Clinical Science) Clinical Pharmaceutical Sciences Manchester Pharmacy School 9 Professors 18 Lecturers/Senior Lecturers/Reader 29 Post doc researchers 7 Teaching Fellows/Senior Teaching

More information

Front Digital page Strategy and Leadership

Front Digital page Strategy and Leadership Front Digital page Strategy and Leadership Who am I? Prof. Dr. Bob de Wit What concerns me? - How to best lead a firm - How to design the strategy process - How to best govern a country - How to adapt

More information

Quality Systems, Accreditation and the Food Sector

Quality Systems, Accreditation and the Food Sector Presentation Outline Quality Systems, Accreditation and the Food Sector David Galsworthy Head of Quality Systems Team Central Science Laboratory York, UK My background The Quality Standards Accreditation

More information

Europass Curriculum Vitae

Europass Curriculum Vitae Europass Curriculum Vitae Personal information First name(s) / Surname(s) Address(es) DANEVA, MIMI DINEVA 84 VITOSHA BLVD, 1463 SOFIA, BULGARIA Telephone(s) +359 2 9217 635 (office) Mobile: +359878760508

More information

Brazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma

Brazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma Brazilian industry s activities for international convergence Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma Mission Congregate companies, institutes and association

More information

NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM

NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM NATIONAL GOOD LABORATORY PRACTICE (GLP) COMPLIANCE MONITORING AUTHORITY APPLICATION FORM Document No.GLP-102 Version/Issue No. 3 Issue Date: October, 2007 NATIONAL GLP COMPLIANCE MONITORING AUTHORITY DEPARTMENT

More information

LAW ON TECHNOLOGY TRANSFER 1998

LAW ON TECHNOLOGY TRANSFER 1998 LAW ON TECHNOLOGY TRANSFER 1998 LAW ON TECHNOLOGY TRANSFER May 7, 1998 Ulaanbaatar city CHAPTER ONE COMMON PROVISIONS Article 1. Purpose of the law The purpose of this law is to regulate relationships

More information

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036

Training. Education CALENDAR FEDEGARI TECH CENTERS DM#407036 2016 CALENDAR COLLABORATION IN THE LIFE SCIENCES WORLD Valued customer, The need to increase efficiency and reliability in pharmaceutical manufacturing presents firms with unique opportunities to develop

More information

Chemistry in the Arts

Chemistry in the Arts Skip Navigation Areas ofchemistry ChemistryCareers Next Steps Chemistry in the Arts Opportunities Conservation and Authentication Materials Chemistry Health and Safety Education A career in art conservation

More information

Current Status and Challenges of Bilateral/Multilateral Meetings

Current Status and Challenges of Bilateral/Multilateral Meetings Current Status and Challenges of Bilateral/Multilateral Meetings Junko Sato, PhD International Liaison Officer PMDA 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and

More information

National Aviation Academy

National Aviation Academy Motto Two Main Locations: King Abdullah Economic City (KAEC) - Jeddah Thumamah Airport Riyadh MISSION: To become the leading global aviation academy graduating worldclass aviation professionals and fueling

More information

Timo Kretzschmar. Inspector. Head of Quality Assurance. Sales (mobile devices) Sales Manager. Freelancer. Curriculum vitae PERSONAL INFORMATION

Timo Kretzschmar. Inspector. Head of Quality Assurance. Sales (mobile devices) Sales Manager. Freelancer. Curriculum vitae PERSONAL INFORMATION Curriculum vitae PERSONAL INFORMATION Timo Kretzschmar WORK EXPERIENCE September 2016 Present Inspector BASG - Bundesamt für Sicherheit im Gesundheitswesen (Austria) Inspections in the field of GLP and

More information

OMCL Network of the Council of Europe GENERAL DOCUMENT

OMCL Network of the Council of Europe GENERAL DOCUMENT OMCL Network of the Council of Europe GENERAL DOCUMENT PA/PH/OMCL (09) 87 4R OMCL Network support for the implementation of the CoE MEDICRIME Convention Full document title and reference How the OMCL Network

More information

Office of Pharmaceutical Quality: Why, What, and How?

Office of Pharmaceutical Quality: Why, What, and How? Office of Pharmaceutical Quality: Why, What, and How? Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research NIPTE Annual Scientific Conference

More information

Director General Riccardo Rigillo

Director General Riccardo Rigillo is Director general for Maritime Fisheries and Aquaculture at the Ministry of Agriculture in Rome. He is also the Italian Managing Authority for the European Maritime and Fisheries Fund. As a Counselor

More information

DEVELOPMENT OF SCIENCE, TECNOLOGY, AND INNOVATION IN UKRAINE Oleg Khymenko

DEVELOPMENT OF SCIENCE, TECNOLOGY, AND INNOVATION IN UKRAINE Oleg Khymenko Ministry of Education and Science of Ukraine DEVELOPMENT OF SCIENCE, TECNOLOGY, AND INNOVATION IN UKRAINE Oleg Khymenko Deputy Director of Department Head of Division Department of Scientific and Technical

More information

Health Care Ltd 3M United Kingdom PLC Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company s customers know they can rely on 3M to help make

More information

PUBLIC TRAINING PROGRAM January - June 2019 VENUE: Petaling Jaya, Shah Alam, Kuala Lumpur, Penang, Kuantan, Johore, Kuching, Labuan.

PUBLIC TRAINING PROGRAM January - June 2019 VENUE: Petaling Jaya, Shah Alam, Kuala Lumpur, Penang, Kuantan, Johore, Kuching, Labuan. ISO 9001 Quality Management System. Understanding & Implementing ISO 9001:2015. (CIDB-CCD)(SBL-Khas) 2 14-15 11-12 27-28 Effective Control of Project Documentation. (CIDB-CCD) 2 25-26 13-14 The Hidden

More information

Swissmedic, Swiss Agency for Therapeutic Products

Swissmedic, Swiss Agency for Therapeutic Products PMDA International Forum, 8 February 2014 Swissmedic, Swiss Agency for Therapeutic Products Jürg H. Schnetzer, Executive Director Grüezi. Bonjour. Buongiorno. Allegra. 2 Overview Swissmedic Introduction

More information

Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective

Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective Analytical Methods and Sampling in the New Manufacturing Paradigm a Regulatory Perspective Dr. Øyvind Holte Norwegian Medicines Agency EMA PAT team/ EDQM PAT working party 15 October, 2014, Heidelberg

More information

MAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals

MAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals MAH Responsibilities including the Management of CMOs QP Forum 2017 - Workshop Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals 25 th April 2017 Alexion Pharmaceuticals in Ireland A

More information

DEPARTMENT OF ECONOMICS AND MARKETING

DEPARTMENT OF ECONOMICS AND MARKETING DEPARTMENT OF ECONOMICS AND MARKETING E-mail: kpikafeim@gmail.com Our department was founded in 1984. From the day of founding it is managed by Doctor of Economics, prof. Yakovlev Anatoliy Ivanovich. He

More information

Delicate tasks should be entrusted to safe hands: Medical gases from Messer.

Delicate tasks should be entrusted to safe hands: Medical gases from Messer. Delicate tasks should be entrusted to safe hands: Medical gases from Messer. Everything at hand: Messer as a medical partner. Stefan Messer Chief Executive Officer and owner of Messer Group When medical

More information

Building science, technology and innovation policies

Building science, technology and innovation policies Map of Europe Building science, technology and innovation policies Prof. Dr. sc. tech. Horst Hippler Rector of the University of Karlsruhe innovasia 2005 Conference & Exhibition 21 23 September 2005 Queen

More information

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development

Quality by Design. Innovate Design Development Create value. Correct definition of QbD and its relation to product and process development Innovate Development Create value Quality by Correct definition of QbD and its relation to product and process development Dr John Loveluck 42 Technology Ltd +44 1480 302700 john.loveluck@42technology.com

More information

Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, Dr. Helmut Rockstroh

Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, Dr. Helmut Rockstroh Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, 2015 Dr. Helmut Rockstroh Overview Introduction - Scope Pharmacopoeial + HA Positions Examples / Case Studies Discussion 2 Introduction:

More information

Overview of speakers Biocides Stakeholders Day. 1 September 2015 Helsinki, Finland

Overview of speakers Biocides Stakeholders Day. 1 September 2015 Helsinki, Finland Overview of speakers Biocides Stakeholders Day 1 September 2015 Helsinki, Finland Plenary session 1 Opening Geert Dancet became the first elected Executive Director of the European Chemicals Agency (ECHA)

More information

Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series

Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series CAMO European Pharmaceutical Seminars Jan/Feb 2009 Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series The Increasing Need of Multivariate Analysis for Process Understanding

More information

SCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total

SCIENCE + BEAUTY. Technical Expertise for the Beauty Industry. 6 pages total SCIENCE + BEAUTY Technical Expertise for the Beauty Industry 6 pages total We can help you with a single scientific requirement Or take a full 360 o approach An Experienced Partner Schoon Scientific is

More information

Accreditation Requirements Mapping

Accreditation Requirements Mapping Accreditation Requirements Mapping APPENDIX D Certain design project management topics are difficult to address in curricula based heavily in mathematics, science, and technology. These topics are normally

More information

Association. Innovation in Medicines PDA: A Global. and Manufacturing. David Tainsh, GSK Keith Pugh, MHRA

Association. Innovation in Medicines PDA: A Global. and Manufacturing. David Tainsh, GSK Keith Pugh, MHRA Innovation in Medicines PDA: A Global and Manufacturing Association David Tainsh, GSK Keith Pugh, MHRA Joint Regulators/Industry QbD Workshop 28-29 January 2014 London, UK Introduction Current State We

More information

Programme Specification

Programme Specification Programme Specification Title: Bachelor of Final Award: Bachelor of (BArch Hons) With Exit Awards at: Certificate of Higher Education (CertHE) Diploma of Higher Education (DipHE) To be delivered from:

More information

THE DIGITALISATION CHALLENGES IN LITHUANIAN ENGINEERING INDUSTRY. Darius Lasionis LINPRA Director November 30, 2018 Latvia

THE DIGITALISATION CHALLENGES IN LITHUANIAN ENGINEERING INDUSTRY. Darius Lasionis LINPRA Director November 30, 2018 Latvia THE DIGITALISATION CHALLENGES IN LITHUANIAN ENGINEERING INDUSTRY Darius Lasionis LINPRA Director November 30, 2018 Latvia THE ENGINEERING INDUSTRIES ASSOCIATION OF LITHUANIA (LINPRA) is an independent

More information

The Process Analytical Technology Initiative: PAT and the Pharmacopeias

The Process Analytical Technology Initiative: PAT and the Pharmacopeias The Process Analytical Technology Initiative: PAT and the Pharmacopeias Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science CDER, FDA EDQM Spring Conference, Cannes, 3-43 4 May 2004

More information

Impact of ICH Q9 and the application of Risk Management

Impact of ICH Q9 and the application of Risk Management Safeguarding public health Impact of ICH Q9 and the application of Risk Management An inspector s perspective on the impact on inspectional approaches and expectations Ian Thrussell Strategy and Development

More information

Trst 25, Kumanovo; 1300, Macedonia Sex Male Date of birth 03/12/1954 Nationality Albanian / R.

Trst 25, Kumanovo; 1300, Macedonia Sex Male Date of birth 03/12/1954 Nationality Albanian / R. PERSONAL INFORMATION Lutfi Bina Trst 25, Kumanovo; 1300, Macedonia +389 71 660012 lutfi.bina@unt.edu.mk Sex Male Date of birth 03/12/1954 Nationality Albanian / R. of Macedonia WORK EXPERIENCE Nov 2016-

More information

PROMOTING QUALITY AND STANDARDS

PROMOTING QUALITY AND STANDARDS PROMOTING QUALITY AND STANDARDS 1 PROMOTING QUALITY AND STANDARDS Strengthen capacities of national and regional quality systems (i.e. metrology, standardization and accreditation) Build conformity assessment

More information

FNCA 2009 WORKSHOP ON HUMAN RESOURCE DEVELOPMENT COUNTRY REPORT MALAYSIA JUNE 2009, FUKUI, JAPAN

FNCA 2009 WORKSHOP ON HUMAN RESOURCE DEVELOPMENT COUNTRY REPORT MALAYSIA JUNE 2009, FUKUI, JAPAN FNCA 2009 WORKSHOP ON HUMAN RESOURCE DEVELOPMENT COUNTRY REPORT MALAYSIA 22 25 JUNE 2009, FUKUI, JAPAN 1. INTRODUCTION 2. PRESENT STATUS OF NATIONAL HRD IN SCIENCE &TECHNOLOGY PROGRAM 3. HRD IN NUCLEAR

More information

PETIA DIMITROVA. Country CEO and Chairperson of the Management Board of Eurobank Bulgaria AD (Postbank) Present

PETIA DIMITROVA. Country CEO and Chairperson of the Management Board of Eurobank Bulgaria AD (Postbank) Present CURRICULUM VITAE PETIA DIMITROVA Country CEO and Chairperson of the Management Board of Eurobank Bulgaria AD (Postbank) 1. Professional Experience Record: / Present Chairperson of the Management Board

More information